These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 24830435)

  • 61. Prospects and progress of DNA vaccines for treating hepatitis B.
    Chen M; Jagya N; Bansal R; Frelin L; Sällberg M
    Expert Rev Vaccines; 2016 May; 15(5):629-40. PubMed ID: 26652035
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Advances and challenges in the development of therapeutic DNA vaccines against hepatitis B virus infection.
    Cova L
    Curr Gene Ther; 2014; 14(3):149-60. PubMed ID: 24828255
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Cutaneous transfection and immune responses to intradermal nucleic acid vaccination are significantly enhanced by in vivo electropermeabilization.
    Drabick JJ; Glasspool-Malone J; King A; Malone RW
    Mol Ther; 2001 Feb; 3(2):249-55. PubMed ID: 11237682
    [TBL] [Abstract][Full Text] [Related]  

  • 64. DNA vaccination with electroporation induces increased antibody responses in patients with prostate cancer.
    Low L; Mander A; McCann K; Dearnaley D; Tjelle T; Mathiesen I; Stevenson F; Ottensmeier CH
    Hum Gene Ther; 2009 Nov; 20(11):1269-78. PubMed ID: 19619001
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Electroporation-enhanced delivery of nucleic acid vaccines.
    Broderick KE; Humeau LM
    Expert Rev Vaccines; 2015 Feb; 14(2):195-204. PubMed ID: 25487734
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Enhanced Delivery of DNA or RNA Vaccines by Electroporation.
    Broderick KE; Humeau LM
    Methods Mol Biol; 2017; 1499():193-200. PubMed ID: 27987151
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Topical vaccination of DNA antigens: topical delivery of DNA antigens.
    Choi MJ; Maibach HI
    Skin Pharmacol Appl Skin Physiol; 2003; 16(5):271-82. PubMed ID: 12907832
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Comparison of plasmid DNA preparation methods for direct gene transfer and genetic immunization.
    Davis HL; Schleef M; Moritz P; Mancini M; Schorr J; Whalen RG
    Biotechniques; 1996 Jul; 21(1):92-4, 96-9. PubMed ID: 8816242
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Adipose tissue: a new target for electroporation-enhanced DNA vaccines.
    Fisher PD; Brambila CJ; McCoy JR; Kiosses WB; Mendoza JM; Oh J; Yung BS; Schultheis K; Smith TRF; Broderick KE
    Gene Ther; 2017 Dec; 24(12):757-767. PubMed ID: 29106403
    [TBL] [Abstract][Full Text] [Related]  

  • 70. DNA vaccines, cyberspace and self-help programs.
    Whalen RG
    Intervirology; 1996; 39(1-2):120-5. PubMed ID: 8957678
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Electroporation-based DNA immunisation: translation to the clinic.
    Luxembourg A; Evans CF; Hannaman D
    Expert Opin Biol Ther; 2007 Nov; 7(11):1647-64. PubMed ID: 17961089
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Evaluation of a novel non-penetrating electrode for use in DNA vaccination.
    Donate A; Coppola D; Cruz Y; Heller R
    PLoS One; 2011 Apr; 6(4):e19181. PubMed ID: 21559474
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Electroporation delivery of DNA vaccines: prospects for success.
    Sardesai NY; Weiner DB
    Curr Opin Immunol; 2011 Jun; 23(3):421-9. PubMed ID: 21530212
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Needle-free topical electroporation improves gene expression from plasmids administered in porcine skin.
    Babiuk S; Baca-Estrada ME; Foldvari M; Baizer L; Stout R; Storms M; Rabussay D; Widera G; Babiuk L
    Mol Ther; 2003 Dec; 8(6):992-8. PubMed ID: 14664802
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Enhanced delivery of naked DNA to the skin by non-invasive in vivo electroporation.
    Zhang L; Nolan E; Kreitschitz S; Rabussay DP
    Biochim Biophys Acta; 2002 Aug; 1572(1):1-9. PubMed ID: 12204326
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Gene-based vaccination and screening methods to develop monoclonal antibodies.
    Daftarian MP; Vosoughi A; Lemmon V
    Methods Mol Biol; 2014; 1121():337-46. PubMed ID: 24510837
    [TBL] [Abstract][Full Text] [Related]  

  • 77. DNA-based immunization against hepatitis B: experience with animal models.
    Davis HL
    Curr Top Microbiol Immunol; 1998; 226():57-68. PubMed ID: 9479835
    [No Abstract]   [Full Text] [Related]  

  • 78. Electroporation for the delivery of DNA-based vaccines and immunotherapeutics: current clinical developments.
    Bodles-Brakhop AM; Heller R; Draghia-Akli R
    Mol Ther; 2009 Apr; 17(4):585-92. PubMed ID: 19223870
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Improving DNA vaccine performance through vector design.
    Williams JA
    Curr Gene Ther; 2014; 14(3):170-89. PubMed ID: 25142448
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A combination of intradermal jet-injection and electroporation overcomes in vivo dose restriction of DNA vaccines.
    Hallengärd D; Bråve A; Isaguliants M; Blomberg P; Enger J; Stout R; King A; Wahren B
    Genet Vaccines Ther; 2012 Aug; 10(1):5. PubMed ID: 22873174
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.